| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 01/17/2008 | US20080014149 Methods and Compositions for Imaging and Biomedical Applications |
| 01/17/2008 | US20080014148 Perturbed membrane-binding compounds and methods of using the same |
| 01/17/2008 | US20080014147 Tumor specific fluorescent dye |
| 01/17/2008 | US20080014146 System and method for determining individualized medical intervention for a disease state |
| 01/17/2008 | US20080014145 Abalone settlement bioassay for anti-seizure substance screening |
| 01/17/2008 | US20080014144 Methods of Treatment with Drug Loaded Polymeric Materials |
| 01/17/2008 | US20080014142 Method of measuring and of selecting compositions of enhanced hydration value |
| 01/17/2008 | US20080014141 Substance Binding Human Igg Fc Receptor Iib (Fcyriib) |
| 01/17/2008 | CA2656504A1 Photo-acoustic detection device and method |
| 01/16/2008 | EP1878799A2 Methods of screening agents for activity using teleosts |
| 01/16/2008 | EP1878447A2 Medium for contrast enhancement or convenience for ultrasonic, endoscopic and other medical examinations |
| 01/16/2008 | EP1878427A1 Novel PPAR ligands that do not cause fluid retention, edema or congestive heart failure |
| 01/16/2008 | EP1877813A2 Mri involving contrast agent with time modulated contrast enhancement |
| 01/16/2008 | EP1877569A1 Predicting treatment response in cancer subjects |
| 01/16/2008 | EP1877103A2 Dendritic polymers with enhanced amplification and interior functionality |
| 01/16/2008 | EP1877100A2 Liposomes |
| 01/16/2008 | EP1483561B1 Light-emitting fusion proteins and diagnostic and therapeutic methods therefor |
| 01/16/2008 | EP1198255B1 Identification of compounds that modify transcriptional responses to hypoxia |
| 01/16/2008 | EP1173480B1 Stereoselective antifibrillogenic peptides |
| 01/16/2008 | EP1077998B1 Labelled glutamine and lysine analogues |
| 01/16/2008 | CN101107016A Contrast agents to target extracellular matrix |
| 01/16/2008 | CN100361711C Diagnostic imaging contrast agents with extended blood retention |
| 01/15/2008 | US7319096 Antiarrhythmia agents; liver disorders; skin disorders |
| 01/15/2008 | US7318917 for drug screening based on the use of fluorescent 4-(4-dimethylaminostyrl)-N-methylpyridinium (ASP+) |
| 01/10/2008 | WO2008005514A2 Polychromatic, diversely-sized particles for angiography |
| 01/10/2008 | WO2008003954A1 Dye imaging agents |
| 01/10/2008 | WO2008003682A1 Non invasive method for assessing mucus clearance |
| 01/10/2008 | WO2008003524A2 Delivery of contrasting agents for magnetic resonance imaging |
| 01/10/2008 | WO2007133551A3 Method for testing drug sensitivity in solid tumors by quantifying mrna expression in thinly-sliced tumor tissue |
| 01/10/2008 | WO2007126758A3 Method and system for determining whether a drug will be effective on a patient with a disease |
| 01/10/2008 | WO2007116954A3 Inorganic nanoparticle comprising an active substance immobilized on the surface and a polymer |
| 01/10/2008 | WO2007105203A3 Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels |
| 01/10/2008 | WO2007104396A3 Method to assess surfactant adsorption on skin |
| 01/10/2008 | WO2007081608A3 Novel gene disruptions, compositions and methods relating thereto |
| 01/10/2008 | WO2004024191A3 Use of metallic particles to improve fluorescence imaging |
| 01/10/2008 | US20080008658 Contrast Agent Formulations for the Visualization of the Lymphatic System |
| 01/10/2008 | US20080008657 Gas- Filled Microvesicles Composition for Contrast Imaging |
| 01/10/2008 | US20080008656 Agent for enhancing contrast of image of fluorescent staining of lumen of digestive tract |
| 01/10/2008 | US20080008655 Cyanine dye bioconjugates useful for diagnostic imaging and therapy; for photoacoustic imaging and detection of tumors; do not aggregate in solution, form starburst dendrimers, are capable of absorbing or omitting light in the near infrared region; Bis(ethylcarboxymethyl)indocyanine Dye |
| 01/10/2008 | US20080008654 Medical devices having a temporary radiopaque coating |
| 01/10/2008 | US20080008653 Models for vaccine assessment |
| 01/10/2008 | US20080008652 Methods and compositions for mediation of immune responses and adjuvant activity |
| 01/10/2008 | US20080008651 Screening Methods and Transgenic Animals for the Treatment of Beta-Globin Related Disease and Conditions |
| 01/10/2008 | US20080008650 Endometriosis cell targeting peptide and uses thereof |
| 01/10/2008 | US20080006266 Optical Pumping Modules, Polarized Gas Blending and Dispensing Systems, and Automated Polarized Gas Distribution Systems and Related Devices and Methods |
| 01/10/2008 | US20080006265 Automated Modular Hyperpolarizers and Related Devices and Methods |
| 01/09/2008 | EP1875928A1 Novel method of using triacetin and auxiliary agent for ultrasonic diagnostic examination |
| 01/09/2008 | EP1875927A1 Methods for evaluating a compound for its effect on skin |
| 01/09/2008 | EP1875904A1 Methods |
| 01/09/2008 | EP1874844A1 Hyperbranched polymers and their applications |
| 01/09/2008 | EP1874370A2 Non-degradable low swelling, water soluble radiopaque hydrogels |
| 01/09/2008 | EP1874335A2 Methods for magnetic resonance imaging |
| 01/09/2008 | EP1651287B1 Injectable composite for the magnetocytolysis of bone metastatic cells |
| 01/09/2008 | EP1434604A4 4-haloethenylphenyl tropane:serotonin transporter imaging agents |
| 01/09/2008 | EP1307237B9 Complexes containing perfluoroalkyl with polar radicals, method for the production and use thereof |
| 01/09/2008 | CN101102799A Method of cardiac imaging with the use of hyperpolarized 13c-pyruvate |
| 01/09/2008 | CN101102717A Method of detecting myocardial dysfunction in patients having a history of asthma or bronchospasm |
| 01/09/2008 | CN100360534C Separation of regioisomers of metal phthalocyanines |
| 01/09/2008 | CN100360126C Method for treating ischemic stroke with melatonin |
| 01/08/2008 | CA2121716C Method and medical agent for diagnosis of arthritis |
| 01/03/2008 | WO2008002815A2 Anti-adhesion sheet |
| 01/03/2008 | WO2008000070A1 Glycyrrhetinic acid derivatives |
| 01/03/2008 | US20080004747 Automated dynamic pressure-responsive dispensing systems, and associated methods and computer program products |
| 01/03/2008 | US20080003295 Bioadhesive nanoparticulate compositions having cationic surface stabilizers |
| 01/03/2008 | US20080003293 Use of Buckysome or Carbon Nanotube for Drug Delivery |
| 01/03/2008 | US20080003217 Ilk inhibitors for the treatment of renal disease |
| 01/03/2008 | US20080003184 Superparamagnetic Gadolinium Oxide Nanoscale Particles and Compositions Comprising Such Particles |
| 01/03/2008 | US20080003183 Nanoparticle radiosensitizers |
| 01/03/2008 | US20080003182 Shortened Carbon Nanotubes |
| 01/03/2008 | US20080003180 Aging Biomarker |
| 01/03/2008 | US20080003179 Methods for measuring rates of reverse cholesterol transport in vivo, as an index of anti-atherogenesis |
| 01/03/2008 | DE102007027689A1 Contrast improving agent from an aqueous solution useful for a fluorescence coloring of the lumen of the digestive tract through intravenously obtained fluorescence dye |
| 01/03/2008 | CA2653726A1 Glycyrrhetinic acid derivatives |
| 01/02/2008 | EP1873544A2 Apparatus for magnetic resonance imaging using hyperpolarized noble gases |
| 01/02/2008 | EP1871427A2 Use of nothobranchius furzeri as a model system for the characterization of drugs that control ageing |
| 01/02/2008 | EP1871421A1 Photosensitizers and mri enhancers |
| 01/02/2008 | EP1871331A2 Composition for treatment of menopause |
| 01/02/2008 | EP1651201B1 Necrosis avid tracer agent |
| 01/02/2008 | EP1548027B1 Compound binding to leukocytes and medicinal composition containing the compound in labeled state as the active ingredient |
| 01/02/2008 | EP1272161B1 Lipid-based drug delivery systems against parasitic infections |
| 01/02/2008 | EP1028978B1 Methods of preparing glycosylated antibodies and antibody fragments having reactive ketone groups |
| 01/02/2008 | CN101095958A Method for preparing 2 type diabetes rat model |
| 01/02/2008 | CN100358584C Novel compositions magnetic particles covered with gem-bisphosphonate derivatives |
| 01/02/2008 | CN100358583C Gadolinium-doped nanometer composite material, and its prepn. method |
| 01/02/2008 | CN100358582C Early senile dementia alpha beta starch spot imaging agent |
| 01/01/2008 | US7314883 (+-)-3-(1H-Indazol-5-yl)-2-{[4-(2-oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidine-1-carbonyl]-amino}-propionic acid to treat neurogenic vasodilation, neurogenic inflammaton, thermal injury, circulatory shock, flushing associated with menopause, airway inflammatory diseases |
| 12/27/2007 | WO2007149479A1 Pyrazine derivatives and uses thereof in renal monitoring |
| 12/27/2007 | WO2007149456A2 Methods and compositions for diagnostic and therapeutic targeting of cox-2 |
| 12/27/2007 | WO2007149454A2 Imaging agents for use in magnetic resonance blood flow/perfusion imaging |
| 12/27/2007 | WO2007149142A1 Cryopreservation media and molecule |
| 12/27/2007 | WO2007130590A3 Men1 is a marker and therapeutic target for breast and prostate cancer |
| 12/27/2007 | WO2007070680A3 Optically detectable probes for identification and treatment of tumors |
| 12/27/2007 | WO2006138363A3 Method for identifying modulators of keah6 useful for treating alzheimer's disease |
| 12/27/2007 | US20070299541 Post-biopsy cavity treatment implants and methods |
| 12/27/2007 | US20070299339 Post-biopsy cavity treatment implants and methods |
| 12/27/2007 | US20070299097 Strategy for Leukemia Therapy |
| 12/27/2007 | US20070298420 Cholesterol transport gene |
| 12/27/2007 | US20070297988 Optical probes for in vivo imaging |
| 12/27/2007 | US20070297987 Anti-Adhesion Sheet |
| 12/27/2007 | US20070297986 Screening methods for identifying agents useful for treating or reducing visual impairment in mammals |